Osteocalcin production in vivo and in vitro after 1,25-dihydroxycholecalciferol stimulation comparison of different assays

European Journal of Clinical Chemistry and Clinical Biochemistry

Volumn 34, Issue 9, 1996, Pages 771-775

  Villa, Isabella ^a,b   Banfi, Giuseppe ^b   Daverio, Rita ^a   Resmini, Giuseppina ^a   Rubinacci, Alessandro ^a  

^a Laboratorio di Osteologia   (Italy)

^b SAN RAFFAELE HOSPITAL   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIBODY; CALCITRIOL; OSTEOCALCIN;

ADULT; AGED; ARTICLE; CELL CULTURE; CLINICAL ARTICLE; CONTROLLED STUDY; CULTURE MEDIUM; FEMALE; HUMAN; HUMAN CELL; METHODOLOGY; ORAL DRUG ADMINISTRATION; OSTEOBLAST; OSTEOPOROSIS; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; PROTEIN DETERMINATION; PROTEIN SECRETION; PROTEIN SYNTHESIS; STANDARD;

AGED; CALCITRIOL; FEMALE; HUMANS; IMMUNOENZYME TECHNIQUES; OSTEOCALCIN; RADIOIMMUNOASSAY; REAGENT KITS, DIAGNOSTIC; SENSITIVITY AND SPECIFICITY;

EID: 0029774287     PISSN: 09394974     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (20)

1. Hauschka PV, Lian JB, Cole DEC, Gundberg CM. Osteocalcin and matrix Gla protein: vitamin K-dependent proteins in bone. Physiol Rev 1989; 69:990-1047.
2. Price PA, Williamson MK, Lothringer JW. Origin of the vitamin K-dependent bone protein found in plasma and its clearance by kidney and bone. J Biol Chem 1981; 256:12760-6.
3. Lueken SA, Arnaud SB, Taylor AK, Baylink DJ. Changes in markers of bone formation and résorption in a bed rest model of weightlessness. 1993,8:1433-8.
4. Gundberg CM, Lian JB, Gallop PM. Urinary gamma-carboxyglutamic acid and serum osteocalcin as bone markers: studies in osteoporosis and Paget's disease. J Endocrinol Metab 1983; 57:1221-5.
5. Riggs BL, Mann KG. Assessment of metabolic bone diseases by measurement of serum bone Gla protein. In: Sen A, Thornhill T, editors. Development and diseases of cartilage and bone matrix. New York: Alan R Liss, 1987:177-86.
6. Delmas PD, Wahner HW, Mann KG, Riggs BL. Assessment of bone turnover in postmenopausal osteoporosis by measurement of serum bone Gla protein. J Lab Clin Med 1983; 102:470-6.
7. Whyte MP, Bergfeld MA, Murphy WA, Avioli LV, Teitelbaum SL. Postmenopausal osteoporosis -a heterogeneous disorder as assessed by hystometric analysis of iliac bone from untreated patients. Am J Med 1982; 82:193-202.
8. Delmas PD, Christiansen C, Mann KG, Price PA. Bone gla protein (osteocalcin) assay standardization report. J Bone Min Res 1990; 5:5-11.
9. Kanis JA, Melton III LJ, Christiansen C, Johnston CC, Khaltaev N. Perspective. The diagnosis of osteoporosis. J Bone Min Res 1994; 9:1137-40.
10. Gehron Robey P, Termine JD. Human bone cells in vitro. Calcif Tissue Int 1985; 37:453-60.
11. Banfi G, Daverio R. In vitro stability of osteocalcin [technical brief]. Clim Chem 1994; 40:833-4.
12. Wong MM, Rao GL, Ly H, Hamilton L, Ish-Shalom S, Sturtridge W, et al. In vitro study of osteoblastic cells from patients with idiopathic osteoporosis and comparison with cells from non-osteoporotic controls. Osteoporosis Int 1994; 4:21-31.
13. Price PA, Baukol SA. l,25-dihydroxyvitamin D3 increases synthesis of the vitamin K-dependent bone protein by osteosarcoma cells. J Biol Chem 1980; 255:11660-3.
14. Skj0dt H, Gallagher JA, Beresford JN, Couch M, Poser JW. Vitamin D metabolites regulate osteocalcin synthesis and proliferation of human bone cells in vitro. J Endocrinol 1985; 105:391-6.
15. Beresford JN, Gallagher JA, Poser JW, Russell RGG. Production of osteocalcin by human bone cells in vitro. Effects of 1,25(OH)2D3, 24,25(OH)2D3, PTH and glucocorticoids. Metab Bone Dis Rel Res 1984; 5:229-35.
16. Masters PW, Jones RG, Purves DA, Cooper EH, Cooney JM. Commercial assays for serum osteocalcin give clinically discordant results. Clin Chem 1994; 40:358-63.
17. Delmas PD, Price PA, Mann KG. Validation of bone gla protein (osteocalcin) assay [editorial]. J Bone Min Res 1990; 5:3-4.
18. Bouillon R, Vanderschueren D, Van Herck E, Nielsen HF, Bex M, Meyns W, et al. Homologous radioimmunoassay of human osteocalcin. Clin Chem 1992; 28:2055-60.
19. Diaz Diego EM, Guerrero R, de la Piedra C. Six osteocalcin assays compared. Clin Chem 1994; 40:2071-7.
20. Durham BH, Robinson J, Fraser WD. Differences in the stability of intact osteocalcin in serum, lithium heparin plasma and EDTA plasma. Ann Clin Biochem 1995; 32:422-3.